198 related articles for article (PubMed ID: 29286484)
1. A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells.
Vijayraghavan S; Kantor B
J Vis Exp; 2017 Dec; (130):. PubMed ID: 29286484
[TBL] [Abstract][Full Text] [Related]
2. Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors.
Wang X; Wang Y; Wu X; Wang J; Wang Y; Qiu Z; Chang T; Huang H; Lin RJ; Yee JK
Nat Biotechnol; 2015 Feb; 33(2):175-8. PubMed ID: 25599175
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.
Dong W; Kantor B
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372494
[TBL] [Abstract][Full Text] [Related]
4. Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing.
Ortinski PI; O'Donovan B; Dong X; Kantor B
Mol Ther Methods Clin Dev; 2017 Jun; 5():153-164. PubMed ID: 28497073
[TBL] [Abstract][Full Text] [Related]
5. Transient Expression of Green Fluorescent Protein in Integrase-Defective Lentiviral Vector-Transduced 293T Cell Line.
Nordin F; Hamid ZA; Chan L; Farzaneh F; Hamid MK
Methods Mol Biol; 2016; 1448():159-73. PubMed ID: 27317180
[TBL] [Abstract][Full Text] [Related]
6. Integrase-deficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk.
Chick HE; Nowrouzi A; Fronza R; McDonald RA; Kane NM; Alba R; Delles C; Sessa WC; Schmidt M; Thrasher AJ; Baker AH
Hum Gene Ther; 2012 Dec; 23(12):1247-57. PubMed ID: 22931362
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibition rescues gene knockout levels achieved with integrase-defective lentiviral vectors encoding zinc-finger nucleases.
Pelascini LP; Maggio I; Liu J; Holkers M; Cathomen T; Gonçalves MA
Hum Gene Ther Methods; 2013 Dec; 24(6):399-411. PubMed ID: 24059449
[TBL] [Abstract][Full Text] [Related]
8. The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology.
Luis A
Viruses; 2020 Sep; 12(10):. PubMed ID: 33003492
[TBL] [Abstract][Full Text] [Related]
9. Integration-deficient lentiviral vectors: a slow coming of age.
Wanisch K; Yáñez-Muñoz RJ
Mol Ther; 2009 Aug; 17(8):1316-32. PubMed ID: 19491821
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk.
Mátrai J; Cantore A; Bartholomae CC; Annoni A; Wang W; Acosta-Sanchez A; Samara-Kuko E; De Waele L; Ma L; Genovese P; Damo M; Arens A; Goudy K; Nichols TC; von Kalle C; L Chuah MK; Roncarolo MG; Schmidt M; Vandendriessche T; Naldini L
Hepatology; 2011 May; 53(5):1696-707. PubMed ID: 21520180
[TBL] [Abstract][Full Text] [Related]
11. Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8
Cousin C; Oberkampf M; Felix T; Rosenbaum P; Weil R; Fabrega S; Morante V; Negri D; Cara A; Dadaglio G; Leclerc C
Cell Rep; 2019 Jan; 26(5):1242-1257.e7. PubMed ID: 30699352
[TBL] [Abstract][Full Text] [Related]
12. One-year follow-up of transgene expression by integrase-defective lentiviral vectors and their therapeutic potential in spinocerebellar ataxia model mice.
Saida H; Matsuzaki Y; Takayama K; Iizuka A; Konno A; Yanagi S; Hirai H
Gene Ther; 2014 Sep; 21(9):820-7. PubMed ID: 24989813
[TBL] [Abstract][Full Text] [Related]
13. Generation of Genetic Knockouts in Myeloid Cell Lines Using a Lentiviral CRISPR/Cas9 System.
Baker PJ; Masters SL
Methods Mol Biol; 2018; 1714():41-55. PubMed ID: 29177854
[TBL] [Abstract][Full Text] [Related]
14. Integrase-defective lentiviral vectors--a stage for nonviral integration machineries.
Staunstrup NH; Mikkelsen JG
Curr Gene Ther; 2011 Oct; 11(5):350-62. PubMed ID: 21745178
[TBL] [Abstract][Full Text] [Related]
15. Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors.
Okada Y; Ueshin Y; Hasuwa H; Takumi K; Okabe M; Ikawa M
Genesis; 2009 Apr; 47(4):217-23. PubMed ID: 19208434
[TBL] [Abstract][Full Text] [Related]
16. Integrase-deficient lentivirus: opportunities and challenges for human gene therapy.
Liu KC; Lin BS; Gao AD; Ma HY; Zhao M; Zhang R; Yan HH; Yi XF; Lin SJ; Que JW; Lan XP
Curr Gene Ther; 2014; 14(5):352-64. PubMed ID: 25174579
[TBL] [Abstract][Full Text] [Related]
17. Integrase defective, nonintegrating lentiviral vectors.
Michelini Z; Negri D; Cara A
Methods Mol Biol; 2010; 614():101-10. PubMed ID: 20225038
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Zinc Finger Nucleases Versus CRISPR-Specific Nucleases for Genome Editing of the Wiskott-Aldrich Syndrome Locus.
Gutierrez-Guerrero A; Sanchez-Hernandez S; Galvani G; Pinedo-Gomez J; Martin-Guerra R; Sanchez-Gilabert A; Aguilar-González A; Cobo M; Gregory P; Holmes M; Benabdellah K; Martin F
Hum Gene Ther; 2018 Mar; 29(3):366-380. PubMed ID: 28922955
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.
Philippe S; Sarkis C; Barkats M; Mammeri H; Ladroue C; Petit C; Mallet J; Serguera C
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17684-9. PubMed ID: 17095605
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells.
Pelascini LP; Janssen JM; Gonçalves MA
Hum Gene Ther; 2013 Jan; 24(1):78-96. PubMed ID: 23140481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]